Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Roche introduces Alnylam's hypertension RNAi therapy, Zilebesiran, with a potential transaction value of up to 2.8 billion dollars
Latest Hotspot
3 min read
Roche introduces Alnylam's hypertension RNAi therapy, Zilebesiran, with a potential transaction value of up to 2.8 billion dollars
26 July 2023
On July 24, 2023, Alnylam announced that it has reached a strategic agreement with Roche to develop and commercialize Zilebesiran, Alnylam's RNAi therapeutic drug for the treatment of hypertension.
Read →
An Overview of Organon 's 125 Drug Pipelines ——Top 50 Pharmaceutical Companies R&D Progress
R&D Pipeline
2 min read
An Overview of Organon 's 125 Drug Pipelines ——Top 50 Pharmaceutical Companies R&D Progress
26 July 2023
Organon & Co. is a pharmaceutical organization founded in 2020 and based in Noord-Brabant, Netherlands. The company operates in the field of biomedicine and focuses on the development of drugs for various therapeutic areas.
Read →
An Overview of Jiangsu Hengrui's 257 Drug Pipelines ——Top 50 Pharmaceutical Companies R&D Progress
R&D Pipeline
3 min read
An Overview of Jiangsu Hengrui's 257 Drug Pipelines ——Top 50 Pharmaceutical Companies R&D Progress
26 July 2023
Jiangsu Hengrui Pharmaceutical Group Co. Ltd. is a pharmaceutical organization based in Jiangsu Sheng, China. It was founded in 1996 and has since become a prominent player in the biomedicine field.
Read →
Anaprazole Sodium——Next Generation Proton Pump Inhibitors
Drug Insights
2 min read
Anaprazole Sodium——Next Generation Proton Pump Inhibitors
26 July 2023
Anaprazole Sodium is a small molecule proton pump inhibitor (PPI) developed by Beijing Sihuan Pharmaceutical Co. Ltd., approved by NMPA on June 21, 2023, for the treatment of duodenal ulcers.
Read →
An Overview of Sun Pharmaceutical 's 159 Drug Pipelines ——Top 50 Pharmaceutical Companies R&D Progress
R&D Pipeline
3 min read
An Overview of Sun Pharmaceutical 's 159 Drug Pipelines ——Top 50 Pharmaceutical Companies R&D Progress
26 July 2023
Sun Pharmaceutical Industries Ltd. is a pharmaceutical company based in Maharashtra, India. It was founded in 1983 and has since become one of the largest pharmaceutical companies in India.
Read →
An Overview of Bausch's 230 Drug Pipelines ——Top 50 Pharmaceutical Companies R&D Progress
R&D Pipeline
3 min read
An Overview of Bausch's 230 Drug Pipelines ——Top 50 Pharmaceutical Companies R&D Progress
26 July 2023
Bausch Health Cos., Inc., formerly known as Valeant Pharmaceuticals International, is a pharmaceutical company founded in 1959 and headquartered in Quebec, Canada.
Read →
Targeting the Siglec-9 Immune Checkpoint: A New Approach to Enhance Immunotherapy
Advanced Tech.
5 min read
Targeting the Siglec-9 Immune Checkpoint: A New Approach to Enhance Immunotherapy
25 July 2023
The studies discussed here provide a foundation for the development of novel approaches to improve the efficacy of cancer immunotherapy.
Read →
Delandistrogene moxeparvovec - The first DMD Gene Therapy
Drug Insights
3 min read
Delandistrogene moxeparvovec - The first DMD Gene Therapy
24 July 2023
Delandistrogen moxeparvovec, also known as SRP-9001, trade name ELEVIDYS, is a kind of Adeno-associated virus gene therapy targeting micro dystrophin.
Read →
An Overview of Sumitomo Dainippon's 304 Drug Pipelines ——Top 50 Pharmaceutical Companies R&D Progress
R&D Pipeline
4 min read
An Overview of Sumitomo Dainippon's 304 Drug Pipelines ——Top 50 Pharmaceutical Companies R&D Progress
24 July 2023
Sumitomo Pharma Co., Ltd. is a pharmaceutical organization based in Osaka-fu, Japan. It was founded in 1984 and has since been actively involved in the field of biomedicine.
Read →
An Overview of Grifols's 53 Drug Pipelines ——Top 50 Pharmaceutical Companies R&D Progress
R&D Pipeline
3 min read
An Overview of Grifols's 53 Drug Pipelines ——Top 50 Pharmaceutical Companies R&D Progress
24 July 2023
Grifols SA is a pharmaceutical organization based in Spain that was founded in 1940. The company has a diverse portfolio of drugs targeting various therapeutic areas.
Read →
Efgartigimod—a revolutionary breakthrough in the treatment of myasthenia gravis
Drug Insights
3 min read
Efgartigimod—a revolutionary breakthrough in the treatment of myasthenia gravis
24 July 2023
The current research focus of the drug is to evaluate the efficacy of the drug in patients with severe autoimmune diseases.
Read →
An Overview of Fresenius 's 51 Drug Pipelines ——Top 50 Pharmaceutical Companies R&D Progress
R&D Pipeline
3 min read
An Overview of Fresenius 's 51 Drug Pipelines ——Top 50 Pharmaceutical Companies R&D Progress
24 July 2023
Fresenius SE & Co. KGaA is a pharmaceutical organization that was founded in 1912 and is based in Hessen, Germany.
Read →